Eugene Ruzagira

Summary

Affiliation: MRC/UVRI Uganda Research Unit on AIDS
Country: Uganda

Publications

  1. pmc Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda
    Eugene Ruzagira
    Medical Research Council MRC, Uganda Virus Research Institute UVRI, Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 6:e20684. 2011
  2. doi request reprint Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda
    Eugene Ruzagira
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    Trop Med Int Health 14:196-203. 2009
  3. doi request reprint Haematological and biochemistry laboratory abnormalities associated with splenomegaly in asymptomatic adults in Masaka, Uganda: implications for HIV biomedical prevention trials
    Eugene Ruzagira
    Medical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda
    Trop Med Int Health 15:105-12. 2010
  4. pmc CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial
    Jeremy Day
    Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme Vietnam, Ho Chi Minh City, Vietnam
    Trials 15:441. 2014
  5. pmc HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study
    Eugene Ruzagira
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 6:e24037. 2011
  6. pmc Comparison of HIV incidence estimated in clinical trial and observational cohort settings in a high risk fishing population in Uganda: Implications for sample size estimates
    Andrew Abaasa
    MRC UVRI, Uganda Research Unit on AIDS, Entebbe, Uganda Electronic address
    Vaccine 34:1778-85. 2016
  7. pmc Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda
    Gershim Asiki
    Medical Research Council Uganda Virus Research Institute, Uganda Research Unit on AIDS, P O Box 49, Entebbe, Uganda Electronic address
    Vaccine 31:5055-61. 2013
  8. pmc Effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda: implications for HIV biomedical prevention trials
    Eugene Ruzagira
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 9:e105089. 2014
  9. pmc Creating an African HIV clinical research and prevention trials network: HIV prevalence, incidence and transmission
    Anatoli Kamali
    Medical Research Council Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 10:e0116100. 2015
  10. pmc Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial
    Freddie M Kibengo
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 8:e74314. 2013

Collaborators

Detail Information

Publications11

  1. pmc Prevalence and incidence of HIV in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda
    Eugene Ruzagira
    Medical Research Council MRC, Uganda Virus Research Institute UVRI, Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 6:e20684. 2011
    ..The objective of this study was to estimate the prevalence and incidence of, and determine risk factors for HIV transmission in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda...
  2. doi request reprint Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda
    Eugene Ruzagira
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    Trop Med Int Health 14:196-203. 2009
    ..To assess willingness to participate in HIV vaccine trials and possible barriers to participation...
  3. doi request reprint Haematological and biochemistry laboratory abnormalities associated with splenomegaly in asymptomatic adults in Masaka, Uganda: implications for HIV biomedical prevention trials
    Eugene Ruzagira
    Medical Research Council Uganda Virus Research Institute Uganda Research Unit on AIDS, Entebbe, Uganda
    Trop Med Int Health 15:105-12. 2010
    ..To assess the degree of haematological and biochemistry abnormalities associated with splenomegaly in asymptomatic adults in order to determine whether they may be eligible for inclusion in HIV biomedical prevention trials...
  4. pmc CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial
    Jeremy Day
    Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme Vietnam, Ho Chi Minh City, Vietnam
    Trials 15:441. 2014
    ..The principal research question posed by this study is as follows: does adding dexamethasone to standard antifungal therapy for CM reduce mortality? Dexamethasone is a cheap, readily available, and practicable intervention...
  5. pmc HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study
    Eugene Ruzagira
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 6:e24037. 2011
    ..To determine the incidence of and risk factors for HIV acquisition in a cohort of HIV-uninfected partners from HIV discordant couples in Masaka, Uganda, and to establish its suitability for HIV vaccine trials...
  6. pmc Comparison of HIV incidence estimated in clinical trial and observational cohort settings in a high risk fishing population in Uganda: Implications for sample size estimates
    Andrew Abaasa
    MRC UVRI, Uganda Research Unit on AIDS, Entebbe, Uganda Electronic address
    Vaccine 34:1778-85. 2016
    ..We investigated the HIV risk status of volunteers in a Simulated Vaccine Efficacy Trial (SiVET) nested within a prospective observational cohort of fisher folks in South Western Uganda...
  7. pmc Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda
    Gershim Asiki
    Medical Research Council Uganda Virus Research Institute, Uganda Research Unit on AIDS, P O Box 49, Entebbe, Uganda Electronic address
    Vaccine 31:5055-61. 2013
    ..HIV vaccine efficacy trials conducted in suitable populations are anticipated in sub-Saharan Africa. We assessed the willingness to participate in future vaccine trials among individuals from fishing communities along Lake Victoria, Uganda...
  8. pmc Effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda: implications for HIV biomedical prevention trials
    Eugene Ruzagira
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 9:e105089. 2014
    ..To investigate the effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda and determine its implications for HIV prevention and other clinical trials...
  9. pmc Creating an African HIV clinical research and prevention trials network: HIV prevalence, incidence and transmission
    Anatoli Kamali
    Medical Research Council Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 10:e0116100. 2015
    ..Volunteers with high incidence were successfully identified and enrolled into large scale cohort studies. Over a quarter of new cases in couples acquired infection from persons other than the suspected transmitting partner. ..
  10. pmc Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial
    Freddie M Kibengo
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 8:e74314. 2013
    ..Intermittent regimen may be a feasible alternative. Preclinical studies have demonstrated effectiveness of intermittent PrEP in SHIV prevention among animals. However, little is known about intermittent PrEP regimens...
  11. pmc HIV-1 transmission within marriage in rural Uganda: a longitudinal study
    Samuel Biraro
    Medical Research Council MRC Uganda Virus Research Institute UVRI Uganda Research Unit on AIDS, Entebbe, Uganda
    PLoS ONE 8:e55060. 2013
    ....